FIELD: medicine.
SUBSTANCE: proposed group of inventions relates to medicine. Methods for determining and selecting therapy for a patient and a kit for determining whether a patient can benefit from treatment with a VEGF antagonist are provided. Detection of Cox2 expression in a patient's biological sample is carried out before the introduction of the VEGF antagonist, the level of Cox2 expression is compared with the reference level, where to increase the expression of Cox2 in a patient sample relative to the reference expression level, a patient is identified that is likely to respond to treatment with a VEGF antagonist.
EFFECT: proposed group of inventions provides effective means and methods for determining whether a patient can benefit from treatment with the help of a VEGF antagonist by detecting the expression of Cox2 in a biological sample of the patient.
51 cl, 8 dwg, 4 tbl, 4 ex
Title |
Year |
Author |
Number |
BIOLOGICAL MARKERS FOR IDENTIFYING PATIENTS FOR TREATMENT WITH VEGF ANTAGONISTS |
2013 |
- Bais, Karlos
- Brauer, Mettyu
- Shmidt, Majke
- Singkh, Mallika
|
RU2659173C2 |
DIAGNOSTIC METHODS AND COMPOSITIONS FOR TREATING GLIOBLASTOMA |
2014 |
- Bais Carlos
- Bourgon Richard
- Phillips Heidi
- Sandmann Thomas
|
RU2706968C2 |
COMPOSITIONS AND METHODS OF TREATING AND DIAGNOSING CANCER-RESISTANT CANCER |
2015 |
|
RU2710735C2 |
BIOMARKERS AND METHODS OF TREATING PD-1 AND PD-L1 RELATED CONDITIONS |
2014 |
- Chen, Deniel Shin-Yuj
- Khedzh, Priti
- Koeppen, Khartmut
- Kovanetz, Marsin
|
RU2820869C1 |
BIOMARKERS AND METHODS OF TREATING ASSOCIATED WITH PD-1 AND PD-L1 CONDITIONS |
2014 |
- Chen Daniel Shin-Yu
- Hegde Priti
- Koeppen Hartmut
- Kowanetz Marcin
|
RU2701378C2 |
THERAPEUTIC, DIAGNOSTIC AND PROGNOSTIC METHODS FOR BLADDER CANCER |
2015 |
- Choi, Younjeong
- Kabbarah, Omar
- Kim, Doris
|
RU2739942C2 |
INHIBITION OF DISSEMINATION OF TUMOUR USING Bv8 OR G-CSF ANTAGONISTS |
2010 |
- Ferrara Napoleon
- Kovanetts Martsin Leshek
|
RU2567803C2 |
TREATING LUNG CANCER BY COMBINATION OF ANTI-PD-1 AND OTHER ANTI-CANCER AGENTS |
2015 |
- Feltquate David
- Chen Allen C.
|
RU2695332C2 |
COMPOSITIONS AND METHODS FOR TREATMENT OF MALIGNANT TUMOUR |
2013 |
|
RU2660349C2 |
METHOD FOR NUCLEOSOMES ADDUCTS DETECTION |
2012 |
- Mikallef Yakob Vinsent
- Ekklstoun Mark Edvard
- Khertsog Mariel
|
RU2634266C2 |